Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ketamine as hydrochloride - solution for injection / infusion - ketamine as hydrochloride 10 mg/ml - ketamine - ketamine - as the sole anaesthetic agent for diagnostic and surgical procedures. when used by intravenous or intramuscular injection, ketalar is best suited for short procedures. with additional doses, or by intravenous infusion, ketalar can be used for longer procedures. if skeletal muscle relaxation is desired a muscle relaxant should be used and respiration should be supported. for the induction of anaesthesia prior to the administration of other general anaesthetic agents. to supplement other anaesthetic agents. specific areas of application or types of procedure: when the intramuscular route of administration is preferred. debridement, painful dressings and skin grafting in burned patients as well as other superficial surgical procedures. neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms and lumbar punctures. diagnostic and operative procedures of the eye, ear, nose and mouth including dental extractions.( note: eye movement may persist during ophthalmological procedures). anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided if at all possible. orthopaedic procedures such as closed reduction, manipulation femoral pinning, amputations and biopsies. sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus. cardiac catheterization procedures. caesarian section: as an induction agent in the absence of elevated blood pressure. anaesthesia in the asthmatic patient, either to minimise the risk of an attack of bronchospasm developing or in the presence of bronchospasm where anaesthesia cannot be delayed.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - ketamine hydrochloride - unknown - ketamine hydrochloride anaesthetic active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - ketamine hydrochloride -

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - ketamine - solution for infusion or injection - ketamine 50 mg - anesthetics

Malta - English - Medicines Authority

hameln pharma limited nexus, gloucester business park, gloucester, united kingdom - ketamine - solution for infusion or injection - ketamine 50 milligram(s)/millilitre - anesthetics

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ketamine - solution for injection - ketamine 50 mg/ml - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - esketamine hydrochloride, quantity: 32.3 mg (equivalent: esketamine, qty 28 mg) - spray, nasal - excipient ingredients: disodium edetate; citric acid monohydrate; water for injections; sodium hydroxide - spravato is indicated for treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,spravato is to be initiated in conjunction with a newly initiated oral antidepressant.

Israel - English - Ministry of Health

j-c health care ltd - esketamine as hydrochloride - solution for spray - esketamine as hydrochloride 28 mg/vial - esketamine - spravato, in combination with a ssri or snri, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.spravato, co-administered with oral antidepressant therapy, is indicated in adults with a moderate to severe episode of major depressive disorder, as acute short-term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency.limitations of use: the effectiveness of spravato in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. use of spravato does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of spravato.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - ketamine hydrochloride - parenteral liquid/solution/suspension - ketamine hydrochloride anaesthetic active 100.0 mg/ml - anaesthetics/analgesics - birds | cat | echidna | horse | marsupial | reptile | zoo felidae | aviary bird | breeders | broilers | budgerigars | canaries | - reversal of xylazine based sedation | spasm | anaesthesia